Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist (Q46934817)

26 December 2017

title

Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist (English)

1 reference

26 December 2017

author name string

Michael A Benneyworth

series ordinal

1

1 reference

26 December 2017

Randy L Smith

series ordinal

2

1 reference

26 December 2017

Elaine Sanders-Bush

series ordinal

3

1 reference

26 December 2017

language of work or name

English

0 references

publication date

24 October 2007

1 reference

26 December 2017

published in

Neuropsychopharmacology

1 reference

26 December 2017

volume

33

1 reference

26 December 2017

issue

9

1 reference

26 December 2017

page(s)

2206-2216

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301600

exact match

0 references

cites work

Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Drug discrimination in neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Pharmacology and functions of metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Reversal of Phencyclidine-Induced Dopaminergic Dysregulation by N-Methyl-D-Aspartate Receptor/Glycine-site Agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Glutamate receptor subunits are altered in forebrain and cerebellum in rats chronically exposed to the NMDA receptor antagonist phencyclidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

5-Hydroxytryptamine2A (5-HT2A) receptor regulation in rat prefrontal cortex: interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

A systems model of altered consciousness: integrating natural and drug-induced psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Serotonergic/glutamatergic interactions: the effects of mGlu 2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

The stimulus properties of LSD in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Modulation of group II metabotropic glutamate receptor signaling by chronic cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

7 January 2021

Hypofrontality revisited: a high resolution single photon emission computed tomography study in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

7 January 2021

Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

7 January 2021

Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography (PET)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

7 January 2021

DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

7 January 2021

Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301600

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301600

1 reference

26 December 2017

PubMed ID

17957214

1 reference

26 December 2017